Small study explores how IBD patients and doctors choose telemonitoring
NCT ID NCT07155486
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study interviewed 10 IBD patients and 6 healthcare professionals to understand how they make shared decisions about using telemonitoring versus standard care. The goal is to improve the decision-making process so patients feel more engaged and informed. The study did not test any treatment or device.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors and patients make better, more informed choices about using telemonitoring for IBD care.
- What could go wrong
- This is a small, completed interview study with only 17 participants, so findings may not apply to all IBD patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IBD (INFLAMMATORY BOWEL DISEASE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Franciscus
Rotterdam, 3045PM, Netherlands
-
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, 5223GZ, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple choice sheet curb unneeded opioid prescriptions?
- Giving patients a voice in methadone care: a new approach under the microscope
- Sleep hormone melatonin put to the test for IBD patients with poor sleep
- Which diet do IBD patients prefer? intermittent fasting, mediterranean, or low FODMAP?
- Could a smartwatch and remote coaching cut incontinence after prostate surgery?
- Could a sticky patch on your chest predict heart failure relapse?